MAPK8 and nasopharyngeal carcinoma: This observation is further supported by the finding that the use of EF-24 and a pharmaceutical inhibitor of JNK, JNK-IN-8 exhibited synergistic effects on suppressing TPA-induced invasion responses and MMP-9 activities in NPC (Figure 6).